Professor of Engineering Karl Griswold, Professor of Computer Science Chris Bailey-Kellogg, and grad student Andrew Scott Parker are developing an integrated suite of general methods combining computation and experiment in order to produce immunotolerant variants of therapeutic proteins, in which immunogenicity is reduced while therapeutic activity is maintained.
Thank you to Neukom Institute for its use:
www.neukominstitute.com
HELLO!!!!!
gamer1829 7 months ago 2
Proffessor Grizwooooold!!
Also, first!
mazeman90 7 months ago 3